Impossible
Total Raised
$2.011BInvestors Count
61Deal Terms
7Funding, Valuation & Revenue
16 Fundings
Impossible has raised $2.011B over 16 rounds.
Impossible's latest funding round was a Unattributed VC - II for $4.8M on February 1, 2022.
Impossible's valuation in March 2020 was $4,000M.
Impossible's 2021 revenue was $137M. Impossible's most recent revenue is from 2019.
Sign up for a free demo to see revenue data from 2022, 2020, 2019 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
2/1/2022 | Unattributed VC - II | $4.8M | 1 | |||
11/23/2021 | Series H | $500M | Mirae Asset Global Investments, and Undisclosed Investors | $137M (59.84x) FY 2021 | 29 | |
8/13/2020 | Series G | $200M | Coatue, Mirae Asset Global Investments, Temasek, and XN Capital | 8 | ||
3/16/2020 | Series F | $4,000M | ||||
8/25/2019 | Secondary Market |
Date | 2/1/2022 | 11/23/2021 | 8/13/2020 | 3/16/2020 | 8/25/2019 |
|---|---|---|---|---|---|
Round | Unattributed VC - II | Series H | Series G | Series F | Secondary Market |
Amount | $4.8M | $500M | $200M | ||
Investors | Mirae Asset Global Investments, and Undisclosed Investors | Coatue, Mirae Asset Global Investments, Temasek, and XN Capital | |||
Valuation | $4,000M | ||||
Revenue | $137M (59.84x) FY 2021 | ||||
Sources | 1 | 29 | 8 |
Impossible Deal Terms
7 Deal Terms
Impossible's deal structure is available for 7 funding rounds, including their Series F from March 16, 2020.
Round | Series F | Series E - II | Series D | Series C | Series B |
|---|---|---|---|---|---|
Funding Date | |||||
Pre-Money Valuation | |||||
Post-Money Valuation | |||||
Amount Raised | |||||
Shares Authorized | |||||
Issuance Price | |||||
Dividend Rate | |||||
Liquidation Preferences | |||||
Liquidation Price | |||||
Participation | |||||
Conversion Price | |||||
Anti Dilution | |||||
General Voting | |||||
Board Voting | |||||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series F | |||||||||||||||
Series E - II | |||||||||||||||
Series D | |||||||||||||||
Series C | |||||||||||||||
Series B |
Impossible Investors
61 Investors
Impossible has 61 investors. 1435 Capital invested in Impossible's Unattributed VC - II funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
2/1/2022 | 2/1/2022 | 1 Unattributed VC - II | Venture Capital | New Jersey | ||
8/13/2020 | 11/23/2021 | 2 Series G, Series H (2021) | Asset/Investment Management | South Korea | ||
8/1/2017 | 8/13/2020 | 5 Series E, Convertible Note (2018), Series E - II (2019), Series F (2020), Series G (2020) | Public-Private Partnership | Singapore | ||
Corporation | New York | |||||
Venture Capital | New York |
First funding | 2/1/2022 | 8/13/2020 | 8/1/2017 | ||
|---|---|---|---|---|---|
Last Funding | 2/1/2022 | 11/23/2021 | 8/13/2020 | ||
Investor | |||||
Rounds | 1 Unattributed VC - II | 2 Series G, Series H (2021) | 5 Series E, Convertible Note (2018), Series E - II (2019), Series F (2020), Series G (2020) | ||
Board Seats | |||||
Type | Venture Capital | Asset/Investment Management | Public-Private Partnership | Corporation | Venture Capital |
Location | New Jersey | South Korea | Singapore | New York | New York |
Compare Impossible to Competitors
The Abbot's Butcher produces plant-based protein products within the food industry. The company provides vegan, gluten-free, and non-GMO protein-rich foods that cater to various culinary needs. Their products target consumers who are looking for meat alternatives in their diet. It was founded in 2017 and is based in San Clemente, California.
UPSIDE Foods specializes in the development of cultivated meat products within the food technology sector. The company offers meat grown directly from animal cells. UPSIDE Foods was formerly known as Memphis Meats. It was founded in 2015 and is based in Berkeley, California.
JUST Egg is a food technology company focused on plant-based and cell-cultured food products. The company offers egg alternatives made from plants, cell-cultured meat, and a variety of condiments, primarily serving the restaurant, foodservice, and industrial sectors. JUST Egg was formerly known as Hampton Creek. It was founded in 2011 and is based in Alameda, California.
Prime Roots is a company that creates plant-based protein products in the deli meat alternative sector. Their offerings include a variety of deli meats and bacon substitutes that aim to replicate traditional meats, using ingredients without preservatives. The company serves the foodservice industry and consumers looking for plant-based alternatives to deli meats. Prime Roots was formerly known as Terramino Foods. It was founded in 2017 and is based in Berkeley, California.
Rebellyous Foods specializes in the production of plant-based chicken alternatives within the food industry. Its main offerings include a variety of nuggets, patties, and tenders designed to replicate the taste and texture of traditional chicken products. The company primarily serves the retail, food service, and educational sectors of food options. It was founded in 2017 and is based in Seattle, Washington.
SuperMeat is involved in the production of cultivated meat and operates within the food technology sector. The company produces chicken meat grown directly from cells, providing an alternative to traditional meat. SuperMeat serves the food industry with its approach to meat production. It was founded in 2015 and is based in Tel Aviv, Israel.
Loading...